中文名稱:地法替尼鹽酸鹽 | 英文名稱:Defactinib hydrochloride |
CAS:1073160-26-5 | 保存條件: -20 ℃ |
純度規(guī)格: 98% min | 產(chǎn)品類別: API |
Defactinib, also known as VS-6063 and PF-04554878, is an orally bioavailable, small-molecule focal adhesion kinase (FAK) inhibitor with potential antiangiogenic and antineoplastic activities. FAK inhibitor PF-04554878 inhibits FAK, which may prevent the integrin-mediated activation of several downstream signal transduction pathways, including ERK, JNK/MAPK and PI3K/Akt, thus inhibiting tumor cell migration, proliferation and survival.
Defactinib hydrochloride is a novel FAK inhibitor, which inhibits FAK phosphorylation at the Tyr397 site in a time- and dose-dependent manner.
成立日期 | 2011-08-02 (14年) | 注冊(cè)資本 | 200萬(wàn) |
員工人數(shù) | 1-10人 | 年?duì)I業(yè)額 | ¥ 1000萬(wàn)-5000萬(wàn) |
主營(yíng)行業(yè) | 中間體,醫(yī)藥原料,醫(yī)藥中間體,原料藥 | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠,定制 |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢價(jià) |
VIP6年
|
上海澤葉生物科技有限公司
|
2025-01-10 | |
詢價(jià) |
VIP2年
|
德陽(yáng)思諾生物科技有限公司
|
2025-01-07 | |
¥9888 |
南京昕瑞再生醫(yī)藥科技有限公司
|
2023-11-20 |